Xyrem sodium oxybate: Phase IIIb data

In the double-blind Phase IIIb EXCEEDS trial in about 200 patients, treatment with Xyrem alone or in combination with Provigil met the primary endpoint of reducing EDS compared to placebo (p<0.001). ...